Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis
| dc.contributor.author | Pannell, N. | |
| dc.contributor.author | Joseph, Darren | |
| dc.contributor.author | Ally, Mahmood Moosa Tar Mahomed | |
| dc.contributor.author | Bida, Nndweleni Meshack | |
| dc.contributor.author | Tintinger, Gregory Ronald | |
| dc.date.accessioned | 2022-06-23T11:27:58Z | |
| dc.date.available | 2022-06-23T11:27:58Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Patients with rheumatoid arthritis (RA) may receive Janus kinase (JAK) inhibitors to achieve optimal control of their disease. We report a case of a patient who received a selective JAK1 inhibitor and subsequently developed multiple pulmonary nodules with cavitation. Biopsies confirmed the presence of cryptococcosis and the patient responded well to anti-fungal therapy. | en_US |
| dc.description.department | Internal Medicine | en_US |
| dc.description.librarian | am2022 | en_US |
| dc.description.uri | http://www.ajtccm.org.za/index.php/SARJ | en_US |
| dc.identifier.citation | Pannell, N., Joseph, D., Ally, M.M.T.M. et al. 2021, 'Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis', African Journal of Thoracic and Critical Care Medicine, vol. 27, no. 3, pp. 123-125, doi : 10.7196/AJTCCM.2021.v27i3.116 . | en_US |
| dc.identifier.issn | 2617-0205 | |
| dc.identifier.other | 10.7196/AJTCCM.2021.v27i3.116 | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/85933 | |
| dc.language.iso | en | en_US |
| dc.publisher | South African Medical Association | en_US |
| dc.rights | South African Medical Association | en_US |
| dc.subject | Janus kinase inhibitors | en_US |
| dc.subject | Opportunistic infections | en_US |
| dc.subject | Rheumatoid arthritis (RA) | en_US |
| dc.title | Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis | en_US |
| dc.type | Article | en_US |